Results     05-May-23
Announcements
Alembic Pharmaceuticals consolidated net profit rises 596.17% in the March 2023 quarter
Sales decline 0.66% to Rs 1406.45 crore
Net profit of Alembic Pharmaceuticals rose 596.17% to Rs 152.60 crore in the quarter ended March 2023 as against Rs 21.92 crore during the previous quarter ended March 2022. Sales declined 0.66% to Rs 1406.45 crore in the quarter ended March 2023 as against Rs 1415.74 crore during the previous quarter ended March 2022.

For the full year,net profit declined 34.35% to Rs 341.98 crore in the year ended March 2023 as against Rs 520.94 crore during the previous year ended March 2022. Sales rose 6.54% to Rs 5652.62 crore in the year ended March 2023 as against Rs 5305.79 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales1406.451415.74 -1 5652.625305.79 7
OPM %14.4910.47 -11.9816.48 -
PBDT190.29151.74 25 630.02912.17 -31
PBT116.1728.66 305 354.59625.39 -43
NP152.6021.92 596 341.98520.94 -34

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 48.01% in the December 2023 quarter
 ( Results - Announcements 05-Feb-24   14:52 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
  Alembic Pharma gets USFDA nod for breast cancer drug
 ( Hot Pursuit - 26-Dec-22   09:44 )
  Volumes soar at Lemon Tree Hotels Ltd counter
 ( Hot Pursuit - 02-Jan-24   11:00 )
  Alembic's oncology injectable formulation facility undergoes USFDA inspection
 ( Corporate News - 18-Oct-22   11:25 )
  Alembic Pharmaceuticals reports consolidated net profit of Rs 120.60 crore in the June 2023 quarter
 ( Results - Announcements 04-Aug-23   14:15 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 02-Jan-24   14:30 )
  Alembic Pharmaceuticals to table results
 ( Corporate News - 22-Jul-23   11:01 )
  Alembic's Bioequivalence facility successfully concludes USFDA inspection
 ( Corporate News - 29-Aug-22   13:13 )
  Alembic Pharmaceuticals to conduct AGM
 ( Corporate News - 20-Sep-22   16:05 )
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top